Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

1. pmc.ncbi.nlm.nih.gov › articles › PMC10711341Duloxetine for treating painful neuropathy, chronic pain or ...

   pmc.ncbi.nlm.nih.gov › articles › PMC10711341

   Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy.

2. www.cochrane.org › CD007115Duloxetine for treating painful neuropathy, chronic pain or ...

   www.cochrane.org › CD007115

   • Αποθηκευμένο αντίγραφο

   Duloxetine at 60 mg daily is effective in treating painful diabetic peripheral neuropathy in the short term, with a risk ratio (RR) for ≥ 50% pain reduction at 12 weeks of 1.73 (95% CI 1.44 to 2.08).

3. pubmed.ncbi.nlm.nih.gov › 19821395Duloxetine for treating painful neuropathy or chronic pain

   pubmed.ncbi.nlm.nih.gov › 19821395

   7 Οκτ 2009 · Duloxetine at 60 mg daily is effective in treating painful diabetic peripheral neuropathy in the short-term to 12 weeks with a risk ratio (RR) for 50% pain reduction at 12 weeks of 1.65 (95% confidence interval (CI) 1.34 to 2.03), number needed to treat (NNT) 6 (95% CI 5 to 10).

4. pmc.ncbi.nlm.nih.gov › articles › PMC6544553A Comprehensive Algorithm for Management of Neuropathic Pain

   pmc.ncbi.nlm.nih.gov › articles › PMC6544553

   They have been shown to be effective in the treatment of peripheral neuropathy, post-herpetic neuralgia, and neuropathic pain post–spinal cord injury and of limited effect in radiculopathy, HIV, and chemotherapy-induced peripheral neuropathy [8,46].

5. www.sciencedirect.com › science › articleNeuropathic pain: Evidence based recommendations - ScienceDirect

   www.sciencedirect.com › science › article

   1 Ιουν 2024 · Primary treatments for neuropathic pain include selective serotonin-norepinephrine reuptake inhibitors (SNRIs) such as duloxetine and venlafaxine, gabapentin, tricyclic antidepressants, as well as topical lidocaine and transcutaneous electrical nerve stimulation, which are specifically suggested for focal peripheral neuropathic pain.

6. link.springer.com › article › 10Pharmacological Management of Painful Peripheral Neuropathies: A...

   link.springer.com › article › 10

   • Αποθηκευμένο αντίγραφο

   3 Νοε 2020 · The best available evidence for the management of painful diabetic polyneuropathy (DPN) is for amitriptyline, duloxetine, gabapentin, pregabalin and venlafaxine as monotherapies and oxycodone as add-on therapy (level II of evidence).

7. systematicreviewsjournal.biomedcentral.com › articles › 10Efficacy and safety of duloxetine in painful diabetic peripheral...

   systematicreviewsjournal.biomedcentral.com › articles › 10

   • Αποθηκευμένο αντίγραφο

   21 Μαρ 2023 · Painful diabetic peripheral neuropathy (PDPN) is a key concern in clinical practice. In this systematic review and meta-analysis, we compared duloxetine and placebo treatments in terms of their efficacy and safety in patients with PDPN.